+121.2%
ADI vs MRNA
-25.6%
+146.8%
-32.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.2% | +1.3% | -2.5% | -1.3% |
| 7D | -7.8% | -13.8% | +6.1% | -6.8% |
| 30D | -4.9% | -17.7% | +12.7% | -3.8% |
| 3M | +1.4% | +14.3% | -12.9% | -0.2% |
| 6M | -8.4% | +336.0% | -344.4% | -26.6% |
| YTD | +40.4% | +575.9% | -535.5% | +1.6% |
| 1Y | +64.6% | +724.4% | -659.8% | +14.0% |
| 3Y | +116.1% | +160.8% | -44.7% | +76.0% |
| All | +121.2% | -25.6% | +146.8% | +97.4% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling